Immunotherapy: the third wave in lung cancer treatment (Q86930748)

scientific article published on 01 December 2015

Language	Label	Description	Also known as
English	Immunotherapy: the third wave in lung cancer treatment	scientific article published on 01 December 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

title

Immunotherapy: the third wave in lung cancer treatment (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

David Felix Heigener

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

Martin Reck

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

publication date

1 December 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

published in

The Lancet. Respiratory medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

page(s)

923-924

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

cites work

TGN1412: From Discovery to Disaster

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900429-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900429-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900429-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900429-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900429-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S2213-2600(15)00429-4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

PubMed publication ID

26679022

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26679022

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26679022%20AND%20SRC:MED&resulttype=core&format=json

Immunotherapy: the third wave in lung cancer treatment (Q86930748)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Immunotherapy: the third wave in lung cancer treatment (Q86930748)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search